Your Input: | |||||
BAK1 | BCL2 antagonist/killer 1. (211 aa) | ||||
BRAF | B-Raf proto-oncogene, serine/threonine kinase. (761 aa) | ||||
TPR | Translocated promoter region, nuclear basket protein. (2438 aa) | ||||
RXRG | Retinoid X receptor gamma. (463 aa) | ||||
BAX | BCL2 associated X, apoptosis regulator. (197 aa) | ||||
TCF7L1 | Transcription factor 7 like 1. (562 aa) | ||||
TPM3 | Uncharacterized protein; Belongs to the tropomyosin family. (285 aa) | ||||
NTRK1 | Tyrosine-protein kinase receptor. (796 aa) | ||||
TFG | Trafficking from ER to golgi regulator. (400 aa) | ||||
MAP2K2 | Mitogen-activated protein kinase kinase 2; Belongs to the protein kinase superfamily. (399 aa) | ||||
MYC | Myc proto-oncogene protein; Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Activates the transcription of growth-related genes. (439 aa) | ||||
GADD45A | Growth arrest and DNA damage inducible alpha. (165 aa) | ||||
CCND1 | Cyclin D1; Belongs to the cyclin family. (253 aa) | ||||
NRAS | NRAS proto-oncogene, GTPase. (189 aa) | ||||
NCOA4 | Nuclear receptor coactivator 4. (650 aa) | ||||
MAP2K1 | Mitogen-activated protein kinase kinase 1; Belongs to the protein kinase superfamily. (393 aa) | ||||
CCDC6 | Coiled-coil domain containing 6. (474 aa) | ||||
MAPK1 | Mitogen-activated protein kinase. (330 aa) | ||||
PAX8 | Paired box 8. (486 aa) | ||||
TP53 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. (393 aa) | ||||
CDKN1A | Cyclin dependent kinase inhibitor 1A. (164 aa) | ||||
POLK | DNA polymerase kappa. (870 aa) | ||||
CTNNB1 | Catenin beta 1. (781 aa) | ||||
GADD45G | Growth arrest and DNA damage inducible gamma. (159 aa) | ||||
MAPK3 | Mitogen-activated protein kinase; Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. MAP kinase subfamily. (379 aa) | ||||
KRAS | KRAS proto-oncogene, GTPase. (189 aa) | ||||
LEF1 | Lymphoid enhancer binding factor 1. (399 aa) | ||||
RET | Proto-oncogene tyrosine-protein kinase receptor Ret; Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. (1094 aa) | ||||
RXRB | Retinoid X receptor beta. (542 aa) | ||||
HRAS | HRas proto-oncogene, GTPase. (189 aa) | ||||
ENSRROP00000036580 | Uncharacterized protein. (99 aa) | ||||
GADD45B | Growth arrest and DNA damage inducible beta. (160 aa) | ||||
CDH1 | Cadherin 1; Cadherins are calcium-dependent cell adhesion proteins. (883 aa) | ||||
RXRA | Retinoid X receptor alpha. (481 aa) | ||||
PPARG | Peroxisome proliferator-activated receptor gamma; Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut ho [...] (505 aa) |